Spire Wealth Management’s Strata Critical Medical Inc SRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.02K Hold
763
﹤0.01% 1863
2026
Q1
$3.19K Hold
763
﹤0.01% 1940
2025
Q4
$3.67K Hold
763
﹤0.01% 1978
2025
Q3
$3.86K Hold
763
﹤0.01% 2021
2025
Q2
$3.08K Hold
763
﹤0.01% 2081
2025
Q1
$2.08K Hold
763
﹤0.01% 2270
2024
Q4
$3.24K Hold
763
﹤0.01% 2146
2024
Q3
$2.24K Hold
763
﹤0.01% 1985
2024
Q2
$2.66K Hold
763
﹤0.01% 1958
2024
Q1
$2.18K Sell
763
-374
-33% -$1.15K ﹤0.01% 2074
2023
Q4
$3.22K Hold
1,137
﹤0.01% 2058
2023
Q3
$2.94K Buy
+1,137
New +$3.99K ﹤0.01% 2053
2023
Q2
Sell
-75,420
Closed -$255K 2405
2023
Q1
$255K Buy
+75,420
New +$308K 0.01% 655
2021
Q2
Sell
-16,734
Closed -$180K 2622
2021
Q1
$180K Buy
+16,734
New +$233K ﹤0.01% 1114

Other funds holding SRTA

Spire Wealth Management's SRTA Position: Q2 2026 in Review

Spire Wealth Management held its Strata Critical Medical Inc (SRTA) position steady in Q2 2026 at 763 shares worth $4.02K. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

Spire Wealth Management first reported a position in SRTA in Q1 2021 and has held it in 14 quarters since. The position peaked at $255K in Q1 2023. 8 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Spire Wealth Management held 763 shares of Strata Critical Medical Inc worth $4.02K as of Q2 2026.
  • Spire Wealth Management left its Strata Critical Medical Inc share count unchanged in Q2 2026.
  • Strata Critical Medical Inc made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1863 holding.
  • Spire Wealth Management first reported a position in Strata Critical Medical Inc in Q1 2021 and has held it in 14 quarters since.
  • Spire Wealth Management's Strata Critical Medical Inc position peaked at $255K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.